The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 25, 2019

Filed:

Feb. 04, 2016
Applicants:

Baker Heart and Diabetes Institute, Melbourne, Victoria, AU;

Monash University, Clayton, Victoria, AU;

Inventors:

Rebecca Helen Ritchie, McKinnon, AU;

Cheng Xue Qin, Spotswood, AU;

Arthur Christopoulos, Kew East, AU;

Patrick Michael Sexton, Bundoora, AU;

Jonathan Bayldon Baell, Parkville, AU;

Assignees:

Baker Heart and Diabetes Institute, Melbourne, Victoria, AU;

Monash University, Clayton, Victoria, AU;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/501 (2006.01); A61K 31/50 (2006.01);
U.S. Cl.
CPC ...
A61K 31/501 (2013.01); A61K 31/50 (2013.01);
Abstract

The present invention relates generally to a method of therapeutically or prophylactically treating ischaemia-induced myocardial tissue damage, in particular ischaemia-reperfusion-induced myocardial tissue damage. More particularly, the present invention relates to a method of reducing the extent of ischaemia-induced myocardial tissue damage in a mammal by selectively upregulating FPR1-mediated ERK signalling. The method of the present invention is useful, inter alia, in reducing the extent and/or severity of myocardial tissue damage associated with conditions characterized by myocardial ischaemia or myocardial ischaemia and reperfusion, such as acute myocardial infarction caused by atherosclerotic artery occlusion or blood clot-induced artery occlusion.


Find Patent Forward Citations

Loading…